Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Filings indexed 162 across all filing types
Latest filing 2021-12-16 Notice of Dividend Amou…
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding the setting of a record date for shareholder dividends (주주명부폐쇄 기준일 결정). It specifies the purpose as determining shareholders for the 13th fiscal year profit distribution. While it relates to dividends, it is not the final declaration of the dividend amount itself, but rather a procedural notice regarding the record date for dividend eligibility. Given the specific nature of dividend-related announcements, it falls under the category of dividend-related notices.
2021-12-16 Korean
기타주요경영사항(자율공시)('의약품 회수·폐기 및 잠정 제조중지 명령' 및 '품목허가 취소 및 전제조업무정지 6개월 행정처분 효력정지 신청' 인용 결정)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from PharmaResearchBio regarding a court decision on an administrative order (drug recall, manufacturing suspension, and license cancellation). It details legal proceedings, specifically the court's decision to grant a stay of execution for these administrative actions. Since this document reports on significant legal and regulatory developments involving the company's operations and potential litigation, it falls under the 'Legal Proceedings Report' category.
2021-12-10 Korean
주요사항보고서(영업정지)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding a business suspension (영업정지) due to regulatory administrative actions (product license cancellation and manufacturing suspension). This type of disclosure regarding significant operational changes or regulatory penalties falls under the category of general regulatory announcements for material events.
2021-12-03 Korean
기타시장안내(상장적격성 실질심사 사유 발생)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice from the exchange regarding 'PharmaResearchBio' concerning the occurrence of grounds for a substantive review of listing eligibility due to a business suspension. It is a formal regulatory announcement regarding market status and trading suspension, which fits the 'Regulatory Filings' (RNS) category as it does not fall into specific categories like M&A, dividends, or financial reports.
2021-12-02 Korean
주권매매거래정지기간변경(상장적격성 실질심사 사유 발생)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for PharmaResearchBio due to a review of listing eligibility. It is a specific regulatory announcement concerning market operations and does not fit into categories like financial reports, dividends, or management changes. As it is a formal regulatory notice regarding trading status, it falls under the RNS category.
2021-12-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document is used to report significant changes in share ownership (crossing thresholds) by major shareholders. Based on the provided definitions, this falls under the 'Major Shareholding Notification' category.
2021-11-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.